Progress in Biological Research and Treatment of Pseudomyxoma Peritonei
Pseudomyxoma peritonei (PMP) is a rare disease characterized by extensive peritoneal implantation and mass secretion of mucus after primary mucinous tumors of the appendix or other organ ruptures. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) is currentl...
Main Authors: | Xi Li, Guodong Liu, Wei Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/16/7/1406 |
Similar Items
-
Neoadjuvant Intraperitoneal Chemotherapy in Patients with Pseudomyxoma Peritonei—A Novel Treatment Approach
by: Aruna Prabhu, et al.
Published: (2020-08-01) -
Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept
by: Olivia Sgarbura, et al.
Published: (2020-01-01) -
Anesthetic management for cytoreductive surgery of pseudomyxoma peritonei with high intra-abdominal pressure: A case report
by: Yan-Jun Lin, et al.
Published: (2023-01-01) -
Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
by: Xin Zhao, et al.
Published: (2023-02-01) -
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
by: Ebbe Billmann Thorgersen, et al.
Published: (2018-09-01)